Purpose This study aimed to assess the outcome and factors associated with mortality in
patients who received urgent chemotherapy (CT) in the intensive care unit (ICU) in Lyon …

Introduction Cardiovascular diseases present a great burden for survivors of hematologic
malignancy (HM). However, the effect of pulmonary hypertension (PH) on the clinical …

Patients with hematological malignancies are at significant risk of systemic and organ-
specific dysfunctions due to disease progression or treatments such as chemotherapy and …

Haematological malignancy (HM) has different causes, including many myeloid or lymphoid
diseases, such as lymphoma, acute or chronic leukaemia and myelodysplastic or …

Patients with hematologic malignancy may develop systemic or organ-specific dysfunction
due to the primary disease progression, its ongoing treatment (chemotherapy and …